SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-007611
Filing Date
2022-02-14
Accepted
2022-02-14 16:59:21
Documents
79
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1221_inmedpharma.htm   iXBRL 10-Q 917822
2 CERTIFICATION f10q1221ex31-1_inmedpharma.htm EX-31.1 11355
3 CERTIFICATION f10q1221ex31-2_inmedpharma.htm EX-31.2 11341
4 CERTIFICATION f10q1221ex32-1_inmedpharma.htm EX-32.1 3018
5 CERTIFICATION f10q1221ex32-2_inmedpharma.htm EX-32.2 2990
11 GRAPHIC image_001.jpg GRAPHIC 13138
  Complete submission text file 0001213900-22-007611.txt   4713434

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20211231.xsd EX-101.SCH 69657
7 XBRL CALCULATION FILE inm-20211231_cal.xml EX-101.CAL 29490
8 XBRL DEFINITION FILE inm-20211231_def.xml EX-101.DEF 234569
9 XBRL LABEL FILE inm-20211231_lab.xml EX-101.LAB 486074
10 XBRL PRESENTATION FILE inm-20211231_pre.xml EX-101.PRE 247174
73 EXTRACTED XBRL INSTANCE DOCUMENT f10q1221_inmedpharma_htm.xml XML 461541
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 22634130
SIC: 2834 Pharmaceutical Preparations